investment
Envigo invests in expansion of surgical facility in response to rising demand
Provider of products and research services, Envigo, has announced it is investing in an expansion of its surgical facility located in Livermore, California, USA, in response to rising demand from West Coast companies. more
PCI announces expansion of its Tredegar facility
Pharmaceutical outsourcing services provider, PCI Pharma Services, has announced the expansion of analytical laboratories at its centre of excellence for contained manufacturing in Tredegar, UK. more
Almac completes £20 million investment in cold chain management
Global contract pharmaceutical development and manufacturing organisation (CDMO), Almac Group, has completed a £20 million investment in its cold chain management capabilities with the opening of a facility in Northern Ireland. more
Prokarium raises $10 million for clinical development of thermostable vaccines
UK-based synthetic biology company, Prokarium, has completed an investment round, raising $10 million for the clinical development of vaccines against chlamydia, C.difficile and enteric fever, plus an expansion for the immune-oncology R&D team more
SBRI Healthcare reveals companies to receive further £8.7 million investment
NHS England initiative, SBRI Healthcare, has revealed which companies will benefit from its investment of £8.7 million — aimed at advancing the development of novel technologies to future-proof primary care and GP services. more
Biopharm group continues efforts in fight against antibiotic resistance through investment
Debiopharm Group, international biopharmaceutical group, has continued its efforts in the fight against antibiotic resistance by investing in antibiotic development through acquiring a minority stake in ABAC Therapeutics. more
Ferring to invest 30 million CHF in biotech centre
Specialty biopharmaceutical group, Ferring Pharmaceuticals, has announced its 30 million CHF investment in its new biotech centre in Switzerland. more
Siren completes funding round to bring data investigation platform to new sectors
Specialist in data discovery, knowledge graphs, search and data interaction, Siren, has completed a seed round worth €3 million, which it will use to bring its semantic data investigation platform to new sectors, including life sciences. more
Cambrex announces further investment in US with expansion at Iowa plant
Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has revealed that it will be investing in the expansion of chemical and analytical development capabilities at its Charles City, Iowa plant more
PCI to begin operations at newly expanded European site
International pharmaceutical outsourcing services provider, PCI Clinical Services, has received the green light to begin operations in its newly expanded European Clinical Services Centre of Excellence. more
3P innovation reveals plans to expand UK operations
Engineering consultancy and automation expert, 3P innovation, has announced its plans to expand its UK operations through a new purpose-built facility that will accommodate its next phase of investment and growth. more
Sanofi & Regeneron accelerate and expand investment for cemiplimab and dupilumab
Sanofi and Regeneron have revealed that they will accelerate and expand investment for the clinical development programmes of cemiplimab in oncology and dupilumab in type 2 allergic diseases. more
Recipharm acquires remaining shares in Indian company
Recipharm has taken a step further in its development and growth in the Indian market by acquiring the remaining shares in Nitin Lifesciences. more
Inflection point: Reviewing the industry opportunities, challenges and trends of 2017
With the industry experiencing dramatic change, from regulatory changes to investments in capacity and the uncertainty of the political landscape, we asked several industry heads to review the opportunities, challenges and trends of 2017. more
ABPI research shows a six-fold increase in CVC investment in UK biotech
The Association of the British Pharmaceutical Industry (ABPI) has released research showing that the amount of capital invested alongside corporate venture capital (CVC) in UK biotech increased six-fold between 2010 and 2015. more
Life sciences investment group raises funds to invest in healthcare innovation
European life sciences investment group, LSP has successfully raised €280 million in funding, which will be used to invest in private companies with innovative healthcare products in the field of medical devices, diagnostics and digital health. more
SGS launches new large molecule bioanalytical services at Belgian facility
SGS, a bio/pharmaceutical analytical and bioanalytical contract solutions provider, has launched new large molecule bioanalytical services at its laboratory in Wavre, Belgium. more
GSK welcomes Life Sciences Sector Deal with £40 million investment
Science-led global healthcare company, GlaxoSmithKline (GSK) has welcomed the UK government’s announcement of the Life Sciences Sector Deal, by announcing £40 million investment in genomic research. more
MSD to make landmark investment in UK economy with launch of UK hub
Ahead of the government’s announcement of its industrial strategy, it has been revealed that MSD (also known as Merck) will make a landmark investment into the UK’s economy through the opening of a new UK hub, for the research into future treatments. more
Fund manager invests in spin out immune-oncology company NeoPhore
UK based fund manager, Sixth Element Capital, has announced a £3 million investment in a spin out company from PhoreMost — NeoPhore. more
